Alert: Hydroxycut Suits Have Recently Been Entered
On May one, 2009, there was a recall of fourteen Hydroxycut diet-aid products stemming from a number of reports that folks using the products were developing serious liver issues and other health concerns. Less than a week later, on May 4, the 1st Hydroxycut class action lawsuit was filed against the company that manufactures the products, Iovate Medical Sciences. The Hydroxycut Class Action Lawsuit alleges company failure in informing the public about potential risks of the products. Naturally, it’s too shortly to grasp the suit is going to turn out, but if the company had information which it didn’t divulge to customers, it should definitely be held accountable.
A class action legal action is filed by a bunch of folks, all of whom have similar claims against a certain company. Filing a class action is just as effective, and much less expensive, than filing an individual suit. As a rule, filing a class action legal action will not cost you anything unless there’s a settlement. At that time, the attorney who handled the suit will take his costs from the compensation that was given and then assign the leftover funds to the plaintiffs in the case. Since this is the case, you’ll be ready to file a Hydroxycut class action suit without paying a penny out of your own pocket, which is one of the reasons that class action legal actions became so popular.
The 1st class action suit against Iovate was filed in Canada where the company is found and represents all Canadian voters who sustained health issues due to Hydroxycut products. The FDA recall occurred in the United States where 23 cases of liver disorders and other health issues had been reported. Health Canada did not receive any reports of liver damage caused by the diet products, but they did receive 17 reports concerning people who sustained respiratory, neurological, cardio, and stomach problems as a result of Canadians using the products.
The Hydroxycut Liver Lawsuits alleges that the products without correctly informing the general public of the health risks that they could exposing buyers to. The complaint states that the company failed to publish the information on the product labels stating that users could run the danger of liver and kidney damage as well as stomach, cardio, respiration, and neurological issues. The suit goes on to claim this was a blatant omission on the part of the company which purposely misled buyers concerning the protection of the products.
